Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:38 PM
Ignite Modification Date:
2025-12-24 @ 4:38 PM
NCT ID:
NCT06788366
Eligibility Criteria:
Inclusion criteria:
* Patients with histological or cytological diagnosis of NSCLC
* Stage IV according to investigator's staging procedures (or any locally advanced tumour not feasible for local radical treatment)
* Treatment with at least 1 cycle of mono-immunotherapy or chemo-immunotherapy (as per clinical practice)
* Availability of follow-up
Exclusion criteria:
* Patients with other thoracic tumours non-NSCLC (i.e. SCLC)
* Stage other than IV or feasible for radical treatment upfront
* Treatment within clinical trials (with combination regimens different from the aforementioned combinations)
* Lost to follow-up
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06788366
Study Brief:
Protocol Section:
NCT06788366